A detailed history of Concourse Financial Group Securities, Inc. transactions in Organon & Co. stock. As of the latest transaction made, Concourse Financial Group Securities, Inc. holds 111 shares of OGN stock, worth $1,696. This represents 0.0% of its overall portfolio holdings.

Number of Shares
111
Previous 168 33.93%
Holding current value
$1,696
Previous $3,000 33.33%
% of portfolio
0.0%
Previous 0.0%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 10, 2024

SELL
$18.65 - $23.03 $1,063 - $1,312
-57 Reduced 33.93%
111 $2,000
Q2 2024

Jul 23, 2024

SELL
$17.45 - $21.96 $52 - $65
-3 Reduced 1.75%
168 $3,000
Q1 2024

Apr 30, 2024

SELL
$13.78 - $18.8 $6,063 - $8,272
-440 Reduced 72.01%
171 $3,000
Q4 2023

Feb 07, 2024

BUY
$10.95 - $17.32 $208 - $329
19 Added 3.21%
611 $8,000
Q3 2023

Oct 25, 2023

SELL
$16.59 - $23.77 $879 - $1,259
-53 Reduced 8.22%
592 $10,000
Q2 2023

Aug 10, 2023

SELL
$19.27 - $24.63 $404 - $517
-21 Reduced 3.15%
645 $13,000
Q1 2023

May 15, 2023

SELL
$21.42 - $32.08 $21 - $32
-1 Reduced 0.15%
666 $15,000
Q4 2022

Jan 30, 2023

SELL
$23.31 - $28.61 $5,314 - $6,523
-228 Reduced 25.47%
667 $0
Q3 2022

Nov 15, 2022

BUY
$23.4 - $34.25 $210 - $308
9 Added 1.02%
895 $21,000
Q2 2022

Aug 09, 2022

SELL
$31.66 - $38.9 $1,931 - $2,372
-61 Reduced 6.44%
886 $30,000
Q1 2022

May 09, 2022

SELL
$30.45 - $39.36 $243 - $314
-8 Reduced 0.84%
947 $33,000
Q4 2021

Feb 07, 2022

SELL
$28.67 - $37.13 $27,465 - $35,570
-958 Reduced 50.08%
955 $29,000
Q3 2021

Nov 09, 2021

SELL
$28.63 - $35.64 $20,270 - $25,233
-708 Reduced 27.01%
1,913 $63,000
Q2 2021

Aug 13, 2021

BUY
$28.45 - $38.0 $74,567 - $99,598
2,621 New
2,621 $79,000

Others Institutions Holding OGN

About Organon & Co.


  • Ticker OGN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 254,330,000
  • Market Cap $3.89B
  • Description
  • Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...
More about OGN
Track This Portfolio

Track Concourse Financial Group Securities, Inc. Portfolio

Follow Concourse Financial Group Securities, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Concourse Financial Group Securities, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Concourse Financial Group Securities, Inc. with notifications on news.